Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
HOOSIER ONCOLOGY GROUP
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Phase II Trial of Everolimus or Everolimus Plus Paclitaxel as First-line Therapy in Cisplatin-Ineligible Patients with Advanced Urothelial Carcinoma
UAB 1311: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-Containing Regimen
